Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide

BMJ Case Reports

Volumn , Issue , 2011, Pages

  Alam, Mohamed Aftab ^a   Sami, Sarmad ^a   Babu, Sathish ^a  

^a SCARBOROUGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; THALIDOMIDE; TRANEXAMIC ACID;

AGED; ANEMIA; ANGIODYSPLASIA; ARGON PLASMA COAGULATION; ARTICLE; BLEEDING GASTROINTESTINAL ANGIODYSPLASIA; BLOOD TRANSFUSION; CAPSULE ENDOSCOPY; CASE REPORT; COLONOSCOPY; DOUBLE BALLOON ENTEROSCOPY; ESOPHAGOGASTRODUODENOSCOPY; EXERCISE TOLERANCE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAINTENANCE THERAPY; MALAISE; MELENA; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; SYMPTOMATOLOGY; TREATMENT RESPONSE;

EID: 81055130456     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.08.2011.4585     Document Type: Article

References (17)

1. Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 1999;245:31-9. (Pubitemid 29049140)
2. Dakeishi M, Shioya T, Wada Y, et al. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 2002;19:140-8. (Pubitemid 34121805)
3. Junquera F, Saperas E, de Torres I, et al. Increased expression of angiogenic factors in human colonic angiodysplasia. Am J Gastroenterol 1999;94:1070-4.
4. Bauditz J, Schachschal G, Wedel S, et al. Thalidomide for treatment of severe intestinal bleeding. Gut 2004;53:609-12. (Pubitemid 38372989)
5. D'Amato RJ, Loughnan MS, Flynn E, et al. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 1994;91:4082-5. (Pubitemid 24139577)
6. McBride WG. Thalidomide and congenital abnormalities. Lancet 1961; 2:1358.
7. Marshall JK, Hunt RH. Hormonal therapy for bleeding gastrointestinal mucosal vascular abnormalities: a promising alternative. Eur J Gastroenterol Hepatol 1997;9:521-5. (Pubitemid 27214460)
8. Lewis BS, Salomon P, Rivera-MacMurray S, et al. Does hormonal therapy have any benefi t for bleeding angiodysplasia? J Clin Gastroenterol 1992;15:99-103.
9. Sabbà C, Gallitelli M, Palasciano G. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia. N Engl J Med 2001;345:926.
10. Saba HI, Morelli GA, Logrono LA. Brief report: treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid. N Engl J Med 1994;330:1789-90. (Pubitemid 24177614)
11. Jameson JJ, Cave DR. Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 2004;114:705-9. (Pubitemid 38548784)
12. Sabbà C, Pasculli G, Cirulli A, et al. Rendu-Osler-Weber disease: experience with 56 patients. Ann Ital Med Int 2002;17:173-9.
13. Yaniv E, Preis M, Hadar T, et al. Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial. Laryngoscope 2009;119:284-8.
14. Vase P. Estrogen treatment of hereditary hemorrhagic telangiectasia. A double-blind controlled clinical trial. Acta Med Scand 1981;209:393-6. (Pubitemid 11110988)
15. Bauditz J, Lochs H. Angiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleeding. World J Gastroenterol 2007;13:5979-84. (Pubitemid 350238263)
16. Bowcock SJ, Patrick HE. Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias? Br J Haematol 2009;146:220-2.
17. Lebrin F, Srun S, Raymond K, et al. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med 2010;16:420-8.